Compare Newmont Corporation (NEM) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs 10X Genomics Inc — how do they compare? Newmont Corporation trades at $118.97 (market cap $123.50B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: Newmont Corporation is far larger — about 16.2× 10X Genomics Inc's market cap, and Newmont Corporation pays a 0.89% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| NEM | TXG | |
|---|---|---|
Market Cap | $123.50B | $7.61B |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $58.57 |
52-Week Low | $67.38 | $11.34 |
Enterprise Value | $120.09B | $7.14B |
Dividend Yield | 0.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
